Aclaris Therapeutics
ACRS
ACRS
127 hedge funds and large institutions have $957M invested in Aclaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 26 reducing their positions, and 6 closing their positions.
Holders
127
Holders Change
+12
Holders Change %
+10.43%
% of All Funds
2.2%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
19
Increased
48
Reduced
26
Closed
6
Calls
$362K
Puts
$357K
Net Calls
+$5K
Net Calls Change
-$250K
Top Buyers
| 1 |
1
Walleye Capital
New York
|
$4.25M |
| 2 |
2
Charles Schwab
San Francisco,
California
|
$6.34M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$17.6M |
| 4 |
4
BlackRock
New York
|
$75.7M |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$29.2M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Tudor Investment Corp
Stamford,
Connecticut
| – | -$169K | -12,090 | Closed |
|
|
OQS
127
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$165K | -11,799 | Closed |
|
|
TI
128
Telemetry Investments
New York
| – | -$154K | -11,043 | Closed |
|
|
QCG
129
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$1K | -84 | Closed |
|
130
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -61 | Closed |
|